|
全民健康保險藥品給付規定 / 健保碼及健保價 |
|
See related Zoladex depot inj[諾雷德 持續性注射劑 "阿斯特捷利康"] information |
|
|
|
製造商 |
AstraZeneca |
|
代理/經銷商 |
AstraZeneca |
|
成份 |
Goserelin |
|
適應症 |
Prostate cancer. Breast cancer in pre- & perimenopausal women. Endometriosis, endometrial thinning, uterine fibroids. Assisted reproduction. |
|
用量 |
Adult 1 depot SC inj into the anterior abdominal wall every 28 days. Assisted reproduction 1 depot SC prior to assisted conception. Endometriosis 1 depot SC for max. 6 months. Endometrial thinning 2 depots administered 4 weeks apart, with surgery timed for between 0 & 2 weeks after the 2nd depot. Uterine fibroids 1 depot for up to 3 months pre-op. |
|
過量 |
View Zoladex[諾雷德] overdosage for action to be taken in the event of an overdose. |
|
美國食品藥物管理局之懷孕等級 |
Category X: Studies in animals or human beings have demonstrated foetal abnormalities or there is evidence of foetal risk based on human experience or both, and the risk of the use of the drug in pregnant women clearly outweighs any possible benefit. The drug is contraindicated in women who are or may become pregnant. |
|
禁忌 |
Hypersensitivity to other LHRH analogues. Pregnancy & lactation. Children. |
|
注意事項 |
Men at risk of developing ureteric obstruction or spinal cord compression. Monitor blood glucose in pre-existing DM. Women with known metabolic bone disease, at risk of developing ovarian hyperstimulation syndrome (OHSS) or with polycystic ovarian syndrome. May cause difficulty in dilating the cervix. |
|
不良反應 |
Rash (generally mild). Arthralgia & BP changes. Occasional local reactions at SC inj site. Rarely, hypersensitivity reactions. Male Hot flushes, sweating, decreased potency. Infrequently breast swelling & tenderness. Temporary increase in bone pain. Isolated cases of ureteric obstruction & spinal cord compression recorded. Female Hot flushes, sweating, change in libido, headache, mood changes including depression, vag dryness, change in breast size. Temporary increase in signs & symptoms in breast cancer. Rarely, patients with bony metastases have developed hypercalcemia on initiation of therapy. Assisted reproduction: ovarian hyperstimulation syndrome associated with use of Zoladex in combination with gonadotrophin.
View ADR Monitoring Website[參閱藥物不良反應監測表格] |
|
副作用 |
View Zoladex[諾雷德] side effects |
|
交互作用 |
[Click for Zoladex[諾雷德] detailed prescribing infomation]
View more drug interactions with Zoladex[諾雷德] |
|
儲存 |
View Zoladex[諾雷德] storage conditions for details to ensure optimal shelf-life. |
|
描述 |
View Zoladex[諾雷德] description for details of the chemical structure and excipients (inactive components). |
|
作用 |
View Zoladex[諾雷德] mechanism of action for pharmacodynamics and pharmacokinetics details. |
|
本商品之市售規格 |
|
劑型 |
包裝 |
圖片 |
|
Zoladex 持續性注射劑 |
|
Zoladex 3.6 mg x 1's |
 |
|
|
|
Manufacturer: |
AstraZeneca |
|
Distributor: |
AstraZeneca |
|
|
|
|
